Viemed Healthcare (NASDAQ:VMD) Downgraded to Buy Rating by Wall Street Zen

Wall Street Zen cut shares of Viemed Healthcare (NASDAQ:VMD) from a strong-buy rating to a buy rating in a report published on Saturday morning.

Separately, Weiss Ratings restated a “hold (c)” rating on shares of Viemed Healthcare in a research report on Monday, December 29th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has an average rating of “Hold”.

Viemed Healthcare Stock Performance

VMD stock opened at $7.24 on Friday. The company has a 50-day simple moving average of $6.94 and a 200 day simple moving average of $6.85. The company has a market capitalization of $275.26 million, a P/E ratio of 21.94 and a beta of 1.25. The company has a quick ratio of 1.01, a current ratio of 1.13 and a debt-to-equity ratio of 0.14. Viemed Healthcare has a fifty-two week low of $5.93 and a fifty-two week high of $8.61.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.09 EPS for the quarter, hitting analysts’ consensus estimates of $0.09. The company had revenue of $71.91 million for the quarter, compared to the consensus estimate of $72.00 million. Viemed Healthcare had a net margin of 5.34% and a return on equity of 9.95%.

Institutional Trading of Viemed Healthcare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Quarry LP acquired a new position in Viemed Healthcare in the third quarter worth approximately $48,000. AQR Capital Management LLC bought a new stake in shares of Viemed Healthcare during the 1st quarter worth $90,000. SG Americas Securities LLC acquired a new position in shares of Viemed Healthcare in the 4th quarter worth $101,000. Cardinal Point Capital Management ULC acquired a new stake in shares of Viemed Healthcare during the second quarter worth $128,000. Finally, Intech Investment Management LLC lifted its holdings in shares of Viemed Healthcare by 14.4% during the second quarter. Intech Investment Management LLC now owns 18,612 shares of the company’s stock valued at $129,000 after purchasing an additional 2,349 shares during the last quarter. 74.24% of the stock is owned by institutional investors and hedge funds.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.